Samsung’s Risk Investment Unit is looking to invest in the Startup of Medical Devices based in California, EXO, in a round that could rise to $ 100 million, Bloomberg reportedciting anonymous sources.
The round is being directed by Sands Capital, Bold Capital and Qitby Health Capital, according to the report, and adds that QITB president, Imar Ishrak, would join the Exo Board.
Founded in 2015, EXO manufactures portable medical image devices that use an artificial intelligence combination, medical images and silicon technology for ultrasound exams such as lungs or echocardiograms. The device connects to a smartphone, and medical examiners can scan patients, document and share exam reports using an application.
The company So far he has raised more than $ 320 million in investor funds such as RA Capital Management, Blackrock, Sands Capital, Intel, Sony and Avidity Partners. The company recently raised a $ 220 million round in series C in 2021.
Exo is also in conversations to associate with Samsung Medison Co., which manufactures medical devices for ultrasound diagnoses and digital X -ray systems, according to the report.
Exo, Samsung, Sands Capital, Bold Capital and Qitby Health did not immediately respond to comments requests.